{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:55:02Z","timestamp":1789696502098,"version":"4.0.1"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["no. 31371218"],"award-info":[{"award-number":["no. 31371218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["no. 2020-BS-189"],"award-info":[{"award-number":["no. 2020-BS-189"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Diabetic retinopathy (DR) is a common complication of diabetes mellitus and has been considered a microvascular disease for a long time. However, recent evidence suggests that diabetic retinal neurodegeneration (DRN), which manifests as neuronal apoptosis, a decrease in optic nerve axons, and reactive gliosis, occurs prior to retinal microvascular alterations. Thioredoxin-interacting protein (TXNIP) is an endogenous inhibitor of thioredoxin (Trx), and it acts by inhibiting its reducing capacity, thereby promoting cellular oxidative stress. In addition, it participates in regulating multiple signaling pathways as a member of the \u03b1-arrestin family of proteins. Accumulating evidence suggests that TXNIP is upregulated in diabetes and plays a pivotal role in the pathophysiological process of DR. In this review, we summarized the role of TXNIP in DRN, aiming to provide evidence for DR treatment in the future.<\/jats:p>","DOI":"10.3389\/fnins.2022.957667","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T07:40:21Z","timestamp":1660030821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Thioredoxin-interacting protein in diabetic retinal neurodegeneration: A novel potential therapeutic target for diabetic retinopathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Chengzhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengshuai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e110388","DOI":"10.1371\/journal.pone.0110388","article-title":"Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy.","volume":"9","author":"Abdelsaid","year":"2014","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"695267","DOI":"10.3389\/fphar.2021.695267","article-title":"Autophagy: a novel pharmacological target in diabetic retinopathy.","volume":"12","author":"Adornetto","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1476-5381.2011.01336.x","article-title":"Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.","volume":"164","author":"Al-Gayyar","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","article-title":"Current understanding of the molecular and cellular pathology of diabetic retinopathy.","volume":"17","author":"Antonetti","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"118988","DOI":"10.1016\/j.lfs.2020.118988","article-title":"TXNIP positively regulates the autophagy and apoptosis in the rat m\u00fcller cell of diabetic retinopathy.","volume":"267","author":"Ao","year":"2021","journal-title":"Life Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41591-020-01222-4","article-title":"What\u2019s new in clinical CRISPR?","volume":"27","author":"Arnold","year":"2021","journal-title":"Nat. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e97302","DOI":"10.1371\/journal.pone.0097302","article-title":"The db\/db mouse: a useful model for the study of diabetic retinal neurodegeneration.","volume":"9","author":"Bogdanov","year":"2014","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12031-018-1188-x","article-title":"Molecular mechanisms mediating diabetic retinal neurodegeneration: potential research avenues and therapeutic targets.","volume":"66","author":"Chakravarthy","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.bbrc.2006.06.027","article-title":"Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein.","volume":"346","author":"Chen","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12192-020-01182-1","article-title":"Gambogic acid ameliorates high glucose- and palmitic acid-induced inflammatory response in ARPE-19 cells via activating Nrf2 signaling pathway: ex vivo.","volume":"26","author":"Chen","year":"2021","journal-title":"Cell Stress Chaperones"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0167-4781(94)90242-9","article-title":"Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3.","volume":"1219","author":"Chen","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12986-020-0426-8","article-title":"S-Equol ameliorates insulin secretion failure through Chrebp\/Txnip signaling via modulating PKA\/PP2A activities.","volume":"17","author":"Chen","year":"2020","journal-title":"Nutr. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00011-016-1002-6","article-title":"Activation of the TXNIP\/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.","volume":"66","author":"Chen","year":"2017","journal-title":"Inflamm. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0140-6736(09)62124-3","article-title":"Diabetic retinopathy.","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.yexcr.2013.01.012","article-title":"Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy.","volume":"319","author":"Devi","year":"2013","journal-title":"Exp. Cell Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"438238","DOI":"10.1155\/2012\/438238","article-title":"TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy.","volume":"2012","author":"Devi","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2777","DOI":"10.1038\/cddis.2017.190","article-title":"TXNIP regulates mitophagy in retinal M\u00fcller cells under high-glucose conditions: implications for diabetic retinopathy.","volume":"8","author":"Devi","year":"2017","journal-title":"Cell Death Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"bio038521","DOI":"10.1242\/bio.038521","article-title":"TXNIP mediates high glucose-induced mitophagic flux and lysosome enlargement in human retinal pigment epithelial cells.","volume":"8","author":"Devi","year":"2019","journal-title":"Biol. Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/toxsci\/kfv313","article-title":"MiR-17 downregulation by high glucose stabilizes thioredoxin-interacting protein and removes thioredoxin inhibition on ASK1 leading to apoptosis.","volume":"150","author":"Dong","year":"2016","journal-title":"Toxicol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biocel.2017.11.013","article-title":"Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.","volume":"94","author":"Duan","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"183757","DOI":"10.1016\/j.bbamem.2021.183757","article-title":"TXNIP interaction with GLUT1 depends on PI(4,5)P(2).","volume":"1863","author":"Dykstra","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"174061","DOI":"10.1016\/j.ejphar.2021.174061","article-title":"Inhibition of thioredoxin-interacting protein and inflammasome assembly using verapamil mitigates diabetic retinopathy and pancreatic injury.","volume":"901","author":"Eissa","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fendo.2019.00291","article-title":"O-GlcNacylation links TxNIP to inflammasome activation in pancreatic \u03b2 cells.","volume":"10","author":"Filhoulaud","year":"2019","journal-title":"Front. Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fneur.2020.00733","article-title":"Correlation between thioredoxin-interacting protein and nerve conduction velocity in patients with type 2 diabetes mellitus.","volume":"11","author":"Gao","year":"2020","journal-title":"Front. Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"644121","DOI":"10.3389\/fmed.2021.644121","article-title":"Protective or harmful: the dual roles of autophagy in diabetic retinopathy.","volume":"8","author":"Gong","year":"2021","journal-title":"Front. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1167\/iovs.19-27825","article-title":"miR-590-3p inhibits pyroptosis in diabetic retinopathy by targeting NLRP1 and inactivating the NOX4 signaling pathway.","volume":"60","author":"Gu","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/cs20171454","article-title":"O-Linked \u03b2-N-acetylglucosamine (O-GlcNAc) modification: a new pathway to decode pathogenesis of diabetic retinopathy.","volume":"132","author":"Gurel","year":"2018","journal-title":"Clin. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/db10-0454","article-title":"Diabetic retinopathy: targeting vasoregression.","volume":"60","author":"Hammes","year":"2011","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.3390\/ijms20184424","article-title":"FMK, an inhibitor of p90RSK, inhibits high glucose-induced TXNIP expression via regulation of ChREBP in pancreatic \u03b2 cells.","volume":"20","author":"Han","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","article-title":"Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-txnip-nlrp3 biological axis.","volume":"16","author":"Han","year":"2018","journal-title":"Redox Biol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4615-1885-3_10","article-title":"O-linked N-acetylglucosamine: the \u201cyin-yang\u201d of Ser\/Thr phosphorylation? Nuclear and cytoplasmic glycosylation.","volume":"376","author":"Hart","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.","volume":"80","author":"Hart","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1124\/mol.112.081133","article-title":"Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein.","volume":"82","author":"He","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes.","volume":"65","author":"Hern\u00e1ndez","year":"2016","journal-title":"Diabetes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0327-y","article-title":"Oxidative stress-mediated TXNIP loss causes RPE dysfunction.","volume":"51","author":"Ji Cho","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000444498","article-title":"Vascular changes and neurodegeneration in the early stages of diabetic retinopathy: which comes first?","volume":"56","author":"Jonsson","year":"2016","journal-title":"Ophthalmic Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1091\/mbc.e08-12-1249","article-title":"ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery.","volume":"20","author":"Jung","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2174\/1570159x14666160614095559","article-title":"Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss.","volume":"14","author":"Kad\u0142ubowska","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"23194","DOI":"10.1074\/jbc.M113.473082","article-title":"FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.","volume":"288","author":"Kibbe","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrc.2017.08.087","article-title":"Metformin protects against retinal cell death in diabetic mice.","volume":"492","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay.","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.23880\/oajo-16000147","article-title":"Potentials of gene therapy for diabetic retinopathy: the use of nucleic acid constructs containing a TXNIP promoter.","volume":"3","author":"Lalit","year":"2018","journal-title":"Open Access J. Ophthalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological functions of autophagy genes: a disease perspective.","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1080\/02713683.2018.1501072","article-title":"Fenofibrate ameliorates oxidative stress-induced retinal microvascular dysfunction in diabetic rats.","volume":"43","author":"Li","year":"2018","journal-title":"Curr. Eye Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/ars.2007.9.25","article-title":"Thioredoxin and related molecules\u2013from biology to health and disease.","volume":"9","author":"Lillig","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"B46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00441-018-2974-z","article-title":"Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt\/\u03b2-catenin pathway activation.","volume":"376","author":"Liu","year":"2019","journal-title":"Cell Tissue Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"768029","DOI":"10.3389\/fcvm.2021.768029","article-title":"MiR-17-5p inhibits TXNIP\/NLRP3 inflammasome pathway and suppresses pancreatic \u03b2-cell pyroptosis in diabetic mice.","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","article-title":"The thioredoxin antioxidant system.","volume":"66","author":"Lu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"8193523","DOI":"10.1155\/2018\/8193523","article-title":"Vitamin D(3) Protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS\/TXNIP\/NLRP3 inflammasome pathway.","volume":"2018","author":"Lu","year":"2018","journal-title":"J. Diabetes Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0378-1119(01)00455-3","article-title":"Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene.","volume":"269","author":"Ludwig","year":"2001","journal-title":"Gene"},{"key":"B51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-020-03267-w","article-title":"Sulforaphane delays diabetes-induced retinal photoreceptor cell degeneration.","volume":"382","author":"Lv","year":"2020","journal-title":"Cell Tissue Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.visres.2017.03.003","article-title":"Diabetic retinopathy is a neurodegenerative disorder.","volume":"139","author":"Lynch","year":"2017","journal-title":"Vision Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis.","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1038\/cddis.2011.117","article-title":"A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics.","volume":"2","author":"Nguyen","year":"2011","journal-title":"Cell Death Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"24996","DOI":"10.1074\/jbc.M109.018093","article-title":"Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins.","volume":"284","author":"Patwari","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"21884","DOI":"10.1074\/jbc.M600427200","article-title":"The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange.","volume":"281","author":"Patwari","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1038\/cddis.2010.42","article-title":"Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy.","volume":"1","author":"Perrone","year":"2010","journal-title":"Cell Death Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jcp.21852","article-title":"Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.","volume":"221","author":"Perrone","year":"2009","journal-title":"J. Cell Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00125-012-2506-4","article-title":"Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity.","volume":"55","author":"Poungvarin","year":"2012","journal-title":"Diabetologia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"61350","DOI":"10.18632\/oncotarget.18134","article-title":"Thioredoxin plays a key role in retinal neuropathy prior to endothelial damage in diabetic mice.","volume":"8","author":"Ren","year":"2017","journal-title":"Oncotarget"},{"key":"B62","doi-asserted-by":"publisher","first-page":"109788","DOI":"10.1016\/j.diabres.2022.109788","article-title":"Thioredoxin upregulation delays diabetes-induced photoreceptor cell degeneration via AMPK-mediated autophagy and exosome secretion.","volume":"185","author":"Ren","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1159\/000494787","article-title":"Up-regulation thioredoxin inhibits advanced glycation end products-induced neurodegeneration.","volume":"50","author":"Ren","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.metabol.2017.01.033","article-title":"MondoA\/ChREBP: the usual suspects of transcriptional glucose sensing; Implication in pathophysiology.","volume":"70","author":"Richards","year":"2017","journal-title":"Metabolism"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4940825","DOI":"10.1155\/2019\/4940825","article-title":"Oxidative stress and microvascular alterations in diabetic retinopathy: future therapies.","volume":"2019","author":"Rodr\u00edguez","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"108498","DOI":"10.1016\/j.neuropharm.2021.108498","article-title":"Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy.","volume":"187","author":"Rolev","year":"2021","journal-title":"Neuropharmacology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2174\/1570159x14666160321122900","article-title":"Autophagy in diabetic retinopathy.","volume":"14","author":"Rosa","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3389\/fnins.2019.01172","article-title":"Relationships between neurodegeneration and vascular damage in diabetic retinopathy.","volume":"13","author":"Rossino","year":"2019","journal-title":"Front. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1080\/10408398.2016.1259983","article-title":"Nrf2 targeting by sulforaphane: a potential therapy for cancer treatment.","volume":"58","author":"Russo","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1074\/jbc.M109.034421","article-title":"Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.","volume":"285","author":"Saxena","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"30369","DOI":"10.1074\/jbc.M400549200","article-title":"Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.","volume":"279","author":"Schulze","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00125-009-1274-2","article-title":"Insulin counteracts glucotoxic effects by suppressing thioredoxin-interacting protein production in INS-1E beta cells and in Psammomys obesus pancreatic islets.","volume":"52","author":"Shaked","year":"2009","journal-title":"Diabetologia"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1210\/me.2014-1095","article-title":"Minireview: thioredoxin-interacting protein: regulation and function in the pancreatic \u03b2-cell.","volume":"28","author":"Shalev","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1210\/en.2002-220564","article-title":"Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway.","volume":"143","author":"Shalev","year":"2002","journal-title":"Endocrinology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1016\/j.bbadis.2018.09.029","article-title":"Dysregulated Txnip-ROS-Wnt axis contributes to the impaired ischemic heart repair in diabetic mice.","volume":"1864","author":"Shen","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"10.4172\/2155","DOI":"10.4172\/2155-9570.1000287","article-title":"Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.","volume":"4","author":"Singh","year":"2013","journal-title":"J. Clin. Exp. Ophthalmol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/diseases9040091","article-title":"Potential combination drug therapy to prevent redox stress and mitophagy dysregulation in retinal m\u00fcller cells under high glucose conditions: implications for diabetic retinopathy.","volume":"9","author":"Singh","year":"2021","journal-title":"Diseases"},{"key":"B79","doi-asserted-by":"publisher","first-page":"10.19080\/jojo.2017.04.555643","DOI":"10.19080\/jojo.2017.04.555643","article-title":"The role of Txnip in mitophagy dysregulation and inflammasome activation in diabetic retinopathy: a New Perspective.","volume":"4","author":"Singh","year":"2017","journal-title":"JOJ Ophthalmol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.62.3.22","article-title":"Mitophagy: an emerging target in ocular pathology.","volume":"62","author":"Skeie","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/ars.2011.4137","article-title":"Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.","volume":"16","author":"Spindel","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"B82","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.exer.2008.10.009","article-title":"Regulation of thioredoxin by ceramide in retinal pigment epithelial cells.","volume":"88","author":"Sreekumar","year":"2009","journal-title":"Exp. Eye Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1002\/jcp.30269","article-title":"Melatonin maintains inner blood-retinal barrier via inhibition of p38\/TXNIP\/NF-\u03baB pathway in diabetic retinopathy.","volume":"236","author":"Tang","year":"2021","journal-title":"J. Cell Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"353.e358","DOI":"10.1016\/j.cmet.2020.07.002","article-title":"Identification of an anti-diabetic, orally available small molecule that regulates TXNIP expression and glucagon action.","volume":"32","author":"Thielen","year":"2020","journal-title":"Cell Metab"},{"key":"B85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/med.0000000000000391","article-title":"Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.","volume":"25","author":"Thielen","year":"2018","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1167\/iovs.11-8997","article-title":"Early neurodegeneration in the retina of type 2 diabetic patients.","volume":"53","author":"van Dijk","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/iub.2267","article-title":"Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes.","volume":"72","author":"Wang","year":"2020","journal-title":"IUBMB Life"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/s0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/dmso.S232221","article-title":"Thioredoxin-interacting protein as a novel potential therapeutic target in diabetes mellitus and its underlying complications.","volume":"13","author":"Wondafrash","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.molcel.2013.01.035","article-title":"AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1.","volume":"49","author":"Wu","year":"2013","journal-title":"Mol. Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nm.3287","article-title":"Thioredoxin-interacting protein regulates insulin transcription through microRNA-204.","volume":"19","author":"Xu","year":"2013","journal-title":"Nat. Med."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1556\/2060.2021.00148","article-title":"Luteolin, an aryl hydrocarbon receptor antagonist, alleviates diabetic retinopathy by regulating the NLRP\/NOX4 signalling pathway: experimental and molecular docking study.","author":"Yang","year":"2021","journal-title":"Physiol. Int."},{"key":"B93","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11064-007-9465-z","article-title":"Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats.","volume":"33","author":"Yu","year":"2008","journal-title":"Neurochem. Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2012.12.022","article-title":"Overexpression of thioredoxin-binding protein 2 increases oxidation sensitivity and apoptosis in human lens epithelial cells.","volume":"57","author":"Yu","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/fjc.0000000000001039","article-title":"Circ_0084043 facilitates high glucose-induced retinal pigment epithelial cell injury by activating miR-128-3p\/TXNIP-mediated Wnt\/\u03b2-catenin signaling pathway.","volume":"78","author":"Zhang","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/cbdd.13828","article-title":"W2476 represses TXNIP transcription via dephosphorylation of FOXO1 at Ser319.","volume":"97","author":"Zhong","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.12659\/msm.895916","article-title":"Thioredoxin-interacting protein (TXNIP) suppresses expression of glutamine synthetase by inducing oxidative stress in retinal muller glia under diabetic conditions.","volume":"22","author":"Zhou","year":"2016","journal-title":"Med. Sci. Monit."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.957667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T07:40:25Z","timestamp":1660030825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.957667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":97,"alternative-id":["10.3389\/fnins.2022.957667"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.957667","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"article-number":"957667"}}